Press Releases

Date Title and Summary Additional Formats
08/27/19 Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Presents Financial Guidance
TEANECK, N.J. --(BUSINESS WIRE)--Aug. 27, 2019-- Phibro Animal Health Corporation (NASDAQ:PAHC) today announced its financial results for its fourth quarter and fiscal year ended June 30, 2019 and presented financial guidance for the new fiscal year. Highlights for the June 2019 quarter (compared
View HTML
08/21/19 Phibro Animal Health Corporation to Participate in the Morgan Stanley Annual Global Healthcare Conference
TEANECK, N.J. --(BUSINESS WIRE)--Aug. 21, 2019-- Phibro Animal Health Corporation (NASDAQ:PAHC) announced today it will participate in the Morgan Stanley Annual Global Healthcare Conference being held at the Grand Hyatt Hotel in New York . Chairman, President and Chief Executive Officer Jack
View HTML
08/06/19 Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2019 Results
TEANECK, N.J. --(BUSINESS WIRE)--Aug. 6, 2019-- Phibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its fourth quarter and fiscal year 2019 financial results and fiscal year 2020 financial guidance on Tuesday, August 27, 2019 , after the market closes.
View HTML
08/01/19 Phibro Animal Health Corporation Acquires Business of Osprey Biotechnics, Inc.
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (“Phibro”) (NASDAQ:PAHC) today announced it has acquired the business and assets of Osprey Biotechnics, Inc. (“Osprey”), a privately held developer and marketer of innovative microbial products.
View HTML
07/29/19 Phibro Animal Health Corporation Declares Quarterly Dividend
TEANECK, N.J. , July 29, 2019 (GLOBE NEWSWIRE) -- The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on September 25, 2019 , to stockholders of record at
View HTML
07/08/19 Phibro Animal Health Corporation Announces a Significant Advance in the Development of a Vaccine Against African Swine Fever
TEANECK, N.J. , July 08, 2019 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ:PAHC) today announced it is pursuing patent protection following a significant advance in the on-going development of a vaccine for African Swine Fever (ASF).  This important step in the vaccine development
View HTML
05/06/19 Phibro Animal Health Corporation Declares Quarterly Dividend
TEANECK, N.J. , May 06, 2019 (GLOBE NEWSWIRE) -- The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on June 26, 2019 , to stockholders of record at the
View HTML
05/06/19 Phibro Animal Health Corporation Reports Third Quarter Results
TEANECK, N.J. , May 06, 2019 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ:PAHC) today announced its financial results for its third quarter ended March 31, 2019 . Highlights for the March 2019 quarter (compared to the March 2018 quarter) Net sales of $206 million , a decrease of $3
View HTML
04/16/19 Phibro Animal Health Corporation to Participate in Bank of America Merrill Lynch 2019 Healthcare Conference
TEANECK, N.J. , April 16, 2019 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ:PAHC) announced today it will participate in the Bank of America Merrill Lynch 2019 Healthcare Conference being held at the Encore Wynn, Las Vegas, Nevada . Chairman, President and Chief Executive Officer
View HTML
04/01/19 Phibro Animal Health Corporation to Host Webcast and Conference Call on March 2019 Quarterly Financial Results
TEANECK, N.J. , April 01, 2019 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its third quarter financial results on Monday, May 6, 2019 , after the market closes. Phibro management will host a conference call and webcast on Tuesday, May 7, 2019 at 9:00 AM
View HTML